SAN FRANCISCO (GenomeWeb) – What originally began as an attempt to provide families and clinicians with advice on where they could obtain molecular diagnostic testing for autism has evolved into an effort to push for standardization of such tests.

Researchers from the Hospital for Sick Children in Toronto analyzed next-generation sequencing gene panels being offered by commercial clinical labs to diagnose autism and found that there is very little overlap between the tests in terms of the genes that are included.